一种新型吡喹酮降解物和液体制剂中BHT交联杂质的分离及化学结构分析

IF 2.1 3区 化学 Q2 CHEMISTRY, ORGANIC Tetrahedron Pub Date : 2025-06-01 Epub Date: 2025-03-26 DOI:10.1016/j.tet.2025.134623
Jiangtao He, Abu Rustum
{"title":"一种新型吡喹酮降解物和液体制剂中BHT交联杂质的分离及化学结构分析","authors":"Jiangtao He,&nbsp;Abu Rustum","doi":"10.1016/j.tet.2025.134623","DOIUrl":null,"url":null,"abstract":"<div><div>During the stability test of a liquid finished drug product (topical liquid transdermal formulation), an unexpected unknown peak was observed in the High Performance Liquid Chromatography (HPLC) chromatogram. This finished drug product is used to control mixed infestations of ectoparasites, nematodes, and cestodes in cats. This topical liquid drug product contains three active pharmaceutical ingredients (APIs), esafoxolaner, eprinomectin, and praziquantel. The identity of any new unknown peak (above certain threshold) in any given finished product batch must be established to ensure that the unknown peak is correctly estimated against the parent compound (API). As there are three APIs in this product, an incorrect assignment of the origin and identity of any given impurity will cause either overestimation or underestimation of the impurity, including misleading information on safety. Therefore, the chemical structure and the correct origin/source(s) of this unknown peak need to be determined. Although High Resolution Mass Spectrometry (HRMS) provides valuable information for determining the structure of the impurity associated with this peak, its structure cannot be fully established by HRMS data alone. Hence, this impurity peak was isolated and purified from aged finished drug product stability samples by semi-prep HPLC. Its chemical structure was fully elucidated through Nuclear Magnetic Resonance (NMR) (<sup>1</sup>H, <sup>13</sup>C, and 2D). The results revealed that the impurity was formed through a cross-reaction between a praziquantel degradant and butylated hydroxytoluene (BHT), which is used as an antioxidant in the finished drug product. The experimental details and full structure elucidation data and related information of this unexpected new degradation product peak is reported in this paper. The mechanism of formation of this impurity is proposed based on its positively identified chemical structure. Based on an extensive literature search, it can be concluded that this is the first known report on the definitive identification of the chemical structure and formation mechanisms of this impurity.</div></div>","PeriodicalId":437,"journal":{"name":"Tetrahedron","volume":"178 ","pages":"Article 134623"},"PeriodicalIF":2.1000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Isolation and chemical structure elucidation of a new praziquantel degradant and BHT crosslinked impurity in a liquid finished drug product\",\"authors\":\"Jiangtao He,&nbsp;Abu Rustum\",\"doi\":\"10.1016/j.tet.2025.134623\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>During the stability test of a liquid finished drug product (topical liquid transdermal formulation), an unexpected unknown peak was observed in the High Performance Liquid Chromatography (HPLC) chromatogram. This finished drug product is used to control mixed infestations of ectoparasites, nematodes, and cestodes in cats. This topical liquid drug product contains three active pharmaceutical ingredients (APIs), esafoxolaner, eprinomectin, and praziquantel. The identity of any new unknown peak (above certain threshold) in any given finished product batch must be established to ensure that the unknown peak is correctly estimated against the parent compound (API). As there are three APIs in this product, an incorrect assignment of the origin and identity of any given impurity will cause either overestimation or underestimation of the impurity, including misleading information on safety. Therefore, the chemical structure and the correct origin/source(s) of this unknown peak need to be determined. Although High Resolution Mass Spectrometry (HRMS) provides valuable information for determining the structure of the impurity associated with this peak, its structure cannot be fully established by HRMS data alone. Hence, this impurity peak was isolated and purified from aged finished drug product stability samples by semi-prep HPLC. Its chemical structure was fully elucidated through Nuclear Magnetic Resonance (NMR) (<sup>1</sup>H, <sup>13</sup>C, and 2D). The results revealed that the impurity was formed through a cross-reaction between a praziquantel degradant and butylated hydroxytoluene (BHT), which is used as an antioxidant in the finished drug product. The experimental details and full structure elucidation data and related information of this unexpected new degradation product peak is reported in this paper. The mechanism of formation of this impurity is proposed based on its positively identified chemical structure. Based on an extensive literature search, it can be concluded that this is the first known report on the definitive identification of the chemical structure and formation mechanisms of this impurity.</div></div>\",\"PeriodicalId\":437,\"journal\":{\"name\":\"Tetrahedron\",\"volume\":\"178 \",\"pages\":\"Article 134623\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tetrahedron\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0040402025001796\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, ORGANIC\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tetrahedron","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0040402025001796","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, ORGANIC","Score":null,"Total":0}
引用次数: 0

摘要

在液体成品(外用液体透皮制剂)的稳定性试验中,在高效液相色谱(HPLC)中观察到一个意想不到的未知峰。该药品成品用于控制猫体内寄生虫、线虫和寄生虫的混合感染。这种局部液体药物产品含有三种活性药物成分(api),依普诺菌素,依普诺菌素和吡喹酮。必须确定任何给定成品批次中任何新的未知峰(高于一定阈值)的身份,以确保根据母体化合物(API)正确估计未知峰。由于该产品中有三种原料药,任何给定杂质的来源和标识的错误分配将导致对杂质的高估或低估,包括对安全性的误导性信息。因此,需要确定这个未知峰的化学结构和正确的来源。虽然高分辨率质谱(HRMS)为确定与该峰相关的杂质的结构提供了有价值的信息,但仅靠HRMS数据不能完全确定其结构。因此,该杂质峰是用半制备高效液相色谱法从陈化成品稳定性样品中分离纯化出来的。通过核磁共振(NMR) (1H, 13C, 2D)对其化学结构进行了充分的解析。结果表明,该杂质是由吡喹酮降解剂与丁基羟基甲苯(BHT)交叉反应形成的,BHT在成品中用作抗氧化剂。本文报道了这一意想不到的新降解产物峰的实验细节和全结构解析数据及相关信息。根据其化学结构的确定,提出了该杂质的形成机理。基于广泛的文献检索,可以得出结论,这是关于该杂质的化学结构和形成机制的明确鉴定的第一份已知报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Isolation and chemical structure elucidation of a new praziquantel degradant and BHT crosslinked impurity in a liquid finished drug product
During the stability test of a liquid finished drug product (topical liquid transdermal formulation), an unexpected unknown peak was observed in the High Performance Liquid Chromatography (HPLC) chromatogram. This finished drug product is used to control mixed infestations of ectoparasites, nematodes, and cestodes in cats. This topical liquid drug product contains three active pharmaceutical ingredients (APIs), esafoxolaner, eprinomectin, and praziquantel. The identity of any new unknown peak (above certain threshold) in any given finished product batch must be established to ensure that the unknown peak is correctly estimated against the parent compound (API). As there are three APIs in this product, an incorrect assignment of the origin and identity of any given impurity will cause either overestimation or underestimation of the impurity, including misleading information on safety. Therefore, the chemical structure and the correct origin/source(s) of this unknown peak need to be determined. Although High Resolution Mass Spectrometry (HRMS) provides valuable information for determining the structure of the impurity associated with this peak, its structure cannot be fully established by HRMS data alone. Hence, this impurity peak was isolated and purified from aged finished drug product stability samples by semi-prep HPLC. Its chemical structure was fully elucidated through Nuclear Magnetic Resonance (NMR) (1H, 13C, and 2D). The results revealed that the impurity was formed through a cross-reaction between a praziquantel degradant and butylated hydroxytoluene (BHT), which is used as an antioxidant in the finished drug product. The experimental details and full structure elucidation data and related information of this unexpected new degradation product peak is reported in this paper. The mechanism of formation of this impurity is proposed based on its positively identified chemical structure. Based on an extensive literature search, it can be concluded that this is the first known report on the definitive identification of the chemical structure and formation mechanisms of this impurity.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Tetrahedron
Tetrahedron 化学-有机化学
CiteScore
3.90
自引率
4.80%
发文量
439
审稿时长
34 days
期刊介绍: Tetrahedron publishes full accounts of research having outstanding significance in the broad field of organic chemistry and its related disciplines, such as organic materials and bio-organic chemistry. Regular papers in Tetrahedron are expected to represent detailed accounts of an original study having substantially greater scope and details than that found in a communication, as published in Tetrahedron Letters. Tetrahedron also publishes thematic collections of papers as special issues and ''Reports'', commissioned in-depth reviews providing a comprehensive overview of a research area.
期刊最新文献
The first and stereoselective synthesis of 8-azidocyclooct-4-ene-1,3,6-triol A Pd-catalyzed multi-component annulation approach towards synthesis of substituted indoles and benzodipyrroles Synthesis of indole-substituted novel 2H-chromenes via molecular iodine mediated iodoarylation reaction Tertiary amines as nitrogen surrogates in C–N bond formation: Recent advances and perspectives (4+3)-Cycloadditions
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1